Exploiting the burkholderia pseudomallei acute phase antigen BPSL2765 for structure-based epitope discovery/design in structural vaccinology

Louise J. Gourlay, Claudio Peri, Mario Ferrer-Navarro, Oscar Conchillo-Solé, Alessandro Gori, Darawan Rinchai, Rachael J. Thomas, Olivia L. Champion, Stephen L. Michell, Chidchamai Kewcharoenwong, Arnone Nithichanon, Patricia Lassaux, Lucia Perletti, Renato Longhi, Ganjana Lertmemongkolchai, Richard W. Titball, Xavier Daura, Giorgio Colombo, Martino Bolognesi

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Summary We solved the crystal structure of Burkholderia pseudomallei acute phase antigen BPSL2765 in the context of a structural vaccinology study, in the area of melioidosis vaccine development. Based on the structure, we applied a recently developed method for epitope design that combines computational epitope predictions with in vitro mapping experiments and successfully identified a consensus sequence within the antigen that, when engineered as a synthetic peptide, was selectively immunorecognized to the same extent as the recombinant protein in sera from melioidosis-affected subjects. Antibodies raised against the consensus peptide were successfully tested in opsonization bacterial killing experiments and antibody-dependent agglutination tests of B. pseudomallei. Our strategy represents a step in the development of immunodiagnostics, in the production of specific antibodies and in the optimization of antigens for vaccine development, starting from structural and physicochemical principles.

Original languageEnglish
Pages (from-to)1147-1156
Number of pages10
JournalChemistry and Biology
Volume20
Issue number9
DOIs
Publication statusPublished - 19 Sep 2013
Externally publishedYes

Fingerprint

Burkholderia pseudomallei
Melioidosis
Epitopes
Antigens
Antibodies
Vaccines
Agglutination Tests
Peptides
Consensus Sequence
Recombinant Proteins
Antibody Formation
Crystal structure
Experiments
Serum

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

Exploiting the burkholderia pseudomallei acute phase antigen BPSL2765 for structure-based epitope discovery/design in structural vaccinology. / Gourlay, Louise J.; Peri, Claudio; Ferrer-Navarro, Mario; Conchillo-Solé, Oscar; Gori, Alessandro; Rinchai, Darawan; Thomas, Rachael J.; Champion, Olivia L.; Michell, Stephen L.; Kewcharoenwong, Chidchamai; Nithichanon, Arnone; Lassaux, Patricia; Perletti, Lucia; Longhi, Renato; Lertmemongkolchai, Ganjana; Titball, Richard W.; Daura, Xavier; Colombo, Giorgio; Bolognesi, Martino.

In: Chemistry and Biology, Vol. 20, No. 9, 19.09.2013, p. 1147-1156.

Research output: Contribution to journalArticle

Gourlay, LJ, Peri, C, Ferrer-Navarro, M, Conchillo-Solé, O, Gori, A, Rinchai, D, Thomas, RJ, Champion, OL, Michell, SL, Kewcharoenwong, C, Nithichanon, A, Lassaux, P, Perletti, L, Longhi, R, Lertmemongkolchai, G, Titball, RW, Daura, X, Colombo, G & Bolognesi, M 2013, 'Exploiting the burkholderia pseudomallei acute phase antigen BPSL2765 for structure-based epitope discovery/design in structural vaccinology', Chemistry and Biology, vol. 20, no. 9, pp. 1147-1156. https://doi.org/10.1016/j.chembiol.2013.07.010
Gourlay, Louise J. ; Peri, Claudio ; Ferrer-Navarro, Mario ; Conchillo-Solé, Oscar ; Gori, Alessandro ; Rinchai, Darawan ; Thomas, Rachael J. ; Champion, Olivia L. ; Michell, Stephen L. ; Kewcharoenwong, Chidchamai ; Nithichanon, Arnone ; Lassaux, Patricia ; Perletti, Lucia ; Longhi, Renato ; Lertmemongkolchai, Ganjana ; Titball, Richard W. ; Daura, Xavier ; Colombo, Giorgio ; Bolognesi, Martino. / Exploiting the burkholderia pseudomallei acute phase antigen BPSL2765 for structure-based epitope discovery/design in structural vaccinology. In: Chemistry and Biology. 2013 ; Vol. 20, No. 9. pp. 1147-1156.
@article{622fbafaed6c4e7ba173d59cac21f6bf,
title = "Exploiting the burkholderia pseudomallei acute phase antigen BPSL2765 for structure-based epitope discovery/design in structural vaccinology",
abstract = "Summary We solved the crystal structure of Burkholderia pseudomallei acute phase antigen BPSL2765 in the context of a structural vaccinology study, in the area of melioidosis vaccine development. Based on the structure, we applied a recently developed method for epitope design that combines computational epitope predictions with in vitro mapping experiments and successfully identified a consensus sequence within the antigen that, when engineered as a synthetic peptide, was selectively immunorecognized to the same extent as the recombinant protein in sera from melioidosis-affected subjects. Antibodies raised against the consensus peptide were successfully tested in opsonization bacterial killing experiments and antibody-dependent agglutination tests of B. pseudomallei. Our strategy represents a step in the development of immunodiagnostics, in the production of specific antibodies and in the optimization of antigens for vaccine development, starting from structural and physicochemical principles.",
author = "Gourlay, {Louise J.} and Claudio Peri and Mario Ferrer-Navarro and Oscar Conchillo-Sol{\'e} and Alessandro Gori and Darawan Rinchai and Thomas, {Rachael J.} and Champion, {Olivia L.} and Michell, {Stephen L.} and Chidchamai Kewcharoenwong and Arnone Nithichanon and Patricia Lassaux and Lucia Perletti and Renato Longhi and Ganjana Lertmemongkolchai and Titball, {Richard W.} and Xavier Daura and Giorgio Colombo and Martino Bolognesi",
year = "2013",
month = "9",
day = "19",
doi = "10.1016/j.chembiol.2013.07.010",
language = "English",
volume = "20",
pages = "1147--1156",
journal = "Cell Chemical Biology",
issn = "2451-9448",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Exploiting the burkholderia pseudomallei acute phase antigen BPSL2765 for structure-based epitope discovery/design in structural vaccinology

AU - Gourlay, Louise J.

AU - Peri, Claudio

AU - Ferrer-Navarro, Mario

AU - Conchillo-Solé, Oscar

AU - Gori, Alessandro

AU - Rinchai, Darawan

AU - Thomas, Rachael J.

AU - Champion, Olivia L.

AU - Michell, Stephen L.

AU - Kewcharoenwong, Chidchamai

AU - Nithichanon, Arnone

AU - Lassaux, Patricia

AU - Perletti, Lucia

AU - Longhi, Renato

AU - Lertmemongkolchai, Ganjana

AU - Titball, Richard W.

AU - Daura, Xavier

AU - Colombo, Giorgio

AU - Bolognesi, Martino

PY - 2013/9/19

Y1 - 2013/9/19

N2 - Summary We solved the crystal structure of Burkholderia pseudomallei acute phase antigen BPSL2765 in the context of a structural vaccinology study, in the area of melioidosis vaccine development. Based on the structure, we applied a recently developed method for epitope design that combines computational epitope predictions with in vitro mapping experiments and successfully identified a consensus sequence within the antigen that, when engineered as a synthetic peptide, was selectively immunorecognized to the same extent as the recombinant protein in sera from melioidosis-affected subjects. Antibodies raised against the consensus peptide were successfully tested in opsonization bacterial killing experiments and antibody-dependent agglutination tests of B. pseudomallei. Our strategy represents a step in the development of immunodiagnostics, in the production of specific antibodies and in the optimization of antigens for vaccine development, starting from structural and physicochemical principles.

AB - Summary We solved the crystal structure of Burkholderia pseudomallei acute phase antigen BPSL2765 in the context of a structural vaccinology study, in the area of melioidosis vaccine development. Based on the structure, we applied a recently developed method for epitope design that combines computational epitope predictions with in vitro mapping experiments and successfully identified a consensus sequence within the antigen that, when engineered as a synthetic peptide, was selectively immunorecognized to the same extent as the recombinant protein in sera from melioidosis-affected subjects. Antibodies raised against the consensus peptide were successfully tested in opsonization bacterial killing experiments and antibody-dependent agglutination tests of B. pseudomallei. Our strategy represents a step in the development of immunodiagnostics, in the production of specific antibodies and in the optimization of antigens for vaccine development, starting from structural and physicochemical principles.

UR - http://www.scopus.com/inward/record.url?scp=84884519958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884519958&partnerID=8YFLogxK

U2 - 10.1016/j.chembiol.2013.07.010

DO - 10.1016/j.chembiol.2013.07.010

M3 - Article

C2 - 23993463

AN - SCOPUS:84884519958

VL - 20

SP - 1147

EP - 1156

JO - Cell Chemical Biology

JF - Cell Chemical Biology

SN - 2451-9448

IS - 9

ER -